Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Crossref DOI link: https://doi.org/10.1007/s40268-018-0254-8
Published Online: 2018-11-13
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gardiner, Kyle M.
Tett, Susan E.
Staatz, Christine E.
Text and Data Mining valid from 2018-11-13
Article History
First Online: 13 November 2018
Compliance with Ethical Standards
:
: Kyle Gardiner, Susan Tett and Christine Staatz declare that they have no conflict of interest.